The FDA Center for Drug Evaluation and Research has posted its industry guidance agenda for calendar year 2008. Planned guidance documents address, among many other issues, drug advertising, clinical trial design, drug safety information, and labeling.
Updates by Reed Smith on U.S. legislative & regulatory developments affecting the health care industry